correspond
mingyu
zhu
mengsen
li
mengsenli
afp
earli
serum
growth
factor
foetal
embryon
develop
hepat
oncogenesi
grow
number
investig
afp
tumourspecif
biomark
conclud
afp
import
target
cancer
treatment
afp
also
play
immunomodulatori
role
treatment
sever
autoimmun
diseas
rheumatoid
arthriti
multipl
sclerosi
myasthenia
gravi
thyroid
effort
support
biochem
screen
drug
design
discoveri
attempt
express
purifi
human
afp
bactobac
system
two
key
factor
affect
express
recombin
human
afp
rafp
name
infecti
baculoviru
inoculum
volum
cultur
time
postinfect
optim
maxim
yield
achiev
high
yield
approxim
mgl
harvest
medium
h
incub
period
infect
inoculum
volum
ratio
also
assess
role
rafp
prolifer
human
liver
cancer
cell
line
bel
result
indic
rafp
promot
growth
hepatoma
cell
conclud
method
produc
high
yield
rafp
use
studi
relat
afp
high
level
serum
afp
associ
embryon
develop
cancer
growth
afp
gene
member
famili
albuminoid
gene
includ
serum
albumin
sa
vitamin
dbind
protein
vtdb
afamin
albuminoid
gene
evolv
common
ancestor
exhibit
consider
similar
primari
structur
exampl
human
afp
human
serum
albumin
hsa
share
ident
highli
conserv
cystein
residu
human
afp
consist
amino
acid
molecular
mass
kda
contain
one
glycosyl
site
howev
glycosyl
site
may
link
variou
carbohydr
moieti
structur
carbohydr
moieti
vari
differ
tissu
diseas
studi
found
afp
regul
hepatocellular
growth
differenti
regener
transform
oncogen
growth
process
afp
also
immunomodulatori
molecul
transfer
foetal
afp
placenta
mother
circul
correl
remiss
rheumatoid
arthriti
multipl
sclerosi
autoimmun
disord
recombin
express
human
afp
develop
biopharmaceut
treatment
autoimmun
diseas
human
afp
also
use
bioactiv
molecul
drug
discoveri
studi
cancer
treatment
recombin
express
human
afp
describ
escherichia
coli
express
system
yeast
milk
transgen
goat
human
afp
express
unsatisfi
system
exampl
human
afp
product
e
coli
express
system
yield
inclus
bodi
refold
materi
practic
commerci
product
addit
human
afp
produc
milk
transgen
goat
easili
purifi
present
studi
first
report
high
yield
recombin
human
afp
rafp
bactobac
baculoviru
express
system
also
detect
bioactiv
rafp
human
liver
cancer
cell
line
bel
found
rafp
promot
hepatoma
cell
growth
present
studi
establish
reliabl
conveni
method
express
produc
high
yield
rafp
could
use
drug
screen
structur
function
studi
human
afp
ncbi
nm
ctermin
histag
clone
pfastbac
vector
invitrogen
inc
usa
fusion
sequenc
read
frame
confirm
sequenc
pfastbac
vector
construct
transform
bacteri
cell
extract
bacmid
transfect
cell
use
cellfectin
ii
reagent
invitrogen
inc
usa
obtain
passag
baculovirus
baculovirus
rafp
express
use
bactobac
baculoviru
express
system
invitrogen
inc
usa
process
follow
insect
cell
cultur
insectxpress
proteinfre
medium
lonza
group
ltd
switzerland
without
serum
densiti
cellsml
baculovirus
harvest
transfect
cell
incub
c
day
one
hundr
microlitr
baculoviru
ad
ml
cell
harvest
h
infect
baculovirus
amplifi
two
round
obtain
baculovirus
ten
millilitr
baculovirus
ad
litr
cell
secret
rafp
harvest
medium
h
infect
describ
previous
insect
medium
approxim
ml
contain
secret
rafp
collect
centrifug
rpm
min
supernat
ad
hb
buffer
mm
hepe
ph
mm
nacl
nickel
ni
charg
resin
ge
healthcar
compani
usa
sampl
mix
shaken
h
histag
rafp
supernat
captur
nicharg
resin
elut
mm
imidazol
hb
buffer
elut
rafp
analys
sdspage
reduc
protein
sdspage
sampl
contain
reduc
buffer
dtt
boil
min
nonreduc
protein
sampl
contain
reduc
buffer
heat
cytoplasm
rafp
analys
follow
h
incub
media
harvest
centrifug
rpm
min
cell
pellet
resuspend
ml
hb
buffer
sonic
ice
min
interv
centrifug
rpm
min
supernat
collect
supernat
contain
rafp
protein
purifi
analys
determin
express
level
secret
rafp
describ
recent
h
incub
media
approxim
litr
contain
secret
rafp
harvest
centrifug
rpm
min
supernat
collect
filter
filter
membran
millipor
corp
usa
supernat
concentr
ml
crossflow
filtrat
millipor
corp
usa
buffer
chang
hb
buffer
concentr
centrifug
rpm
min
supernat
collect
pass
nicharg
resin
ge
healthcar
rafp
captur
resin
elut
mm
imidazol
hb
buffer
elut
buffer
concentr
ml
use
kda
filter
tube
millipor
corp
usa
purifi
gel
filtrat
chromatographi
use
superdex
column
ge
healthcar
compani
usa
detect
wavelength
nm
elut
perform
hb
buffer
flow
rate
mlmin
human
cord
blood
afp
precipit
ammonium
sulfat
pass
antiafp
affin
chromatographi
column
afpposit
fraction
collect
concentr
puriti
prepar
afp
determin
sdspage
protein
store
c
use
target
protein
electrophoret
separ
sdspage
electrotransf
protein
transfer
gel
pvdf
membran
constant
voltag
v
h
c
immunodetect
block
buffer
ad
pvdf
membran
membran
rock
gentli
h
membran
rins
tbst
buffer
three
time
appropri
concentr
antiafp
antibodi
ad
membran
rock
gentli
h
c
appropri
concentr
horseradish
peroxidaseconjug
antirabbit
antibodi
ad
membran
rock
gentli
h
c
membran
wash
tbst
buffer
develop
reagent
ad
develop
monitor
antibodi
afp
horseradish
peroxidaseconjug
antirabbit
antibodi
purchas
sangon
biotech
co
ltd
shanghai
jackson
immunor
lab
inc
usa
respect
optim
experi
design
compar
effect
two
major
factor
infecti
baculoviru
inoculum
volum
postinfect
time
product
rafp
experi
perform
infect
cell
cultur
baculoviru
incub
cell
constant
temperatur
c
shake
condit
rpm
harvest
medium
infect
monitor
time
medium
replac
hb
buffer
protein
captur
nicharg
resin
ge
healthcar
compani
usa
elut
mm
imidazol
hb
buffer
elut
histag
protein
concentr
purifi
gel
filtrat
chromatographi
use
superdex
column
final
protein
analys
nanodrop
spectrophotomet
nm
sdspage
describ
recent
monoclon
antibodi
human
afp
antiafp
prepar
accord
standard
procedur
briefli
balbc
mice
immun
purifi
human
afp
sigmaaldrich
complet
freund
adjuv
interv
spleen
cell
remov
immun
mice
myeloma
cell
exponenti
phase
mix
spleen
cell
certain
proport
fuse
buffer
cell
type
cultur
hat
hhypoxanthin
aaminopterin
tthymidin
medium
supplement
feeder
cell
form
hybridoma
cell
line
hybridoma
cell
secret
antibodi
screen
elisa
continu
clone
limit
dilut
method
thu
stabl
antiafp
antibodi
produc
hybridoma
cell
line
obtain
balbc
mice
inocul
posit
clone
antiafp
antibodi
harvest
ascit
fluid
purifi
affin
chromatographi
specif
monoclon
antibodi
titr
higher
afp
ascertain
elisa
western
blot
assay
prevent
interfer
human
albumin
structur
similar
human
afp
result
elisa
western
blot
assay
show
specif
bind
monoclon
antibodi
human
afp
lack
reaction
human
albumin
express
human
afp
receptor
afpr
bel
cell
line
examin
use
laser
confoc
microscop
describ
previous
briefli
bel
cell
incub
mous
antihuman
afpr
antibodi
abcam
biotech
compani
cambridg
uk
h
follow
incub
secondari
goat
antimous
antibodi
conjug
fitc
zhongshan
boil
tech
co
beij
h
dapi
mgml
ad
mixtur
local
express
afpr
cell
observ
captur
laser
confoc
microscopi
leica
tcsnt
germani
bel
cell
suspend
medium
contain
fb
ad
plate
ml
per
well
follow
incub
c
humidifi
atmospher
co
h
supernat
remov
replac
fresh
medium
without
fb
anoth
h
differ
concentr
extract
human
afp
eafp
rafp
mgl
hsa
antiafp
ad
well
h
puls
mci
htdr
cell
harvest
glass
microfibr
filter
h
later
use
multipl
sampl
harvest
incorpor
htdr
measur
use
lkb
rackbeta
liquid
scintil
counter
use
eafp
posit
control
determin
whether
influenc
human
afp
prolifer
specif
blockag
antiafp
hsa
structur
analogu
also
assess
control
group
without
afp
hsa
also
parallel
done
accord
previous
describ
procedur
total
bel
cell
per
well
plate
plate
cultur
medium
supplement
fb
c
humidifi
atmospher
co
h
cultur
cell
medium
replac
medium
without
fb
anoth
h
cell
treat
human
afp
mgl
h
effect
eafp
rafp
cell
growth
measur
mtt
assay
describ
previou
studi
growth
ratio
control
group
treat
group
control
group
express
vector
confirm
agaros
gel
electrophoresi
figur
lane
show
pfastbac
vector
could
digest
bamhi
hindiii
restrict
enzym
releas
band
measur
approxim
bp
confirm
presenc
recombin
human
afp
gene
dna
sequenc
recombin
pfastbac
confirm
exist
code
sequenc
correct
frame
vector
without
mutat
alter
afp
gene
sequenc
figur
lane
show
recombin
bacmid
contain
pfastbac
vector
confirm
correct
homolog
recombin
occur
bacmid
secret
rafp
insect
medium
cytoplasm
rafp
lyse
insect
cell
assess
sdspage
result
shown
figur
nonreduc
nativ
secret
rafp
band
tilt
approxim
kda
indic
protein
nonlinear
form
lane
reduc
protein
band
lane
approxim
kda
consist
size
afp
gene
molecular
mass
cytoplasm
rafp
band
lane
similar
secret
rafp
band
band
faint
impur
result
indic
cytoplasm
rafp
concentr
lower
extracellular
rafp
concentr
medium
cytoplasm
rafp
may
bind
protein
rafp
protein
evalu
western
blot
figur
medium
contain
express
rafp
amplifi
use
largescal
express
recombin
protein
purif
secret
rafp
medium
straightforward
first
medium
concentr
buffer
exchang
use
hb
buffer
second
step
rafp
medium
captur
nicharg
resin
elut
mm
imidazol
purifi
gel
filtrat
chromatographi
elut
chromatographi
posit
rafp
shown
figur
elut
volum
ml
posit
indic
molecular
mass
kda
accord
superdex
column
ge
healthcar
rafp
fraction
gel
filtrat
chromatographi
collect
sdspage
analysi
highest
peak
show
high
concentr
rafp
figur
lane
c
indic
purif
process
success
purifi
rafp
solubl
stabl
test
isoelectr
point
ip
ph
process
analys
rafp
express
found
differ
condit
led
differ
express
level
figur
show
rafp
express
yield
sampl
differ
time
h
express
yield
increas
slowli
optim
yield
rafp
protein
paramet
evalu
systemat
viru
titr
pfuml
cell
densiti
cellsml
infecti
baculoviru
inoculum
volum
rafp
product
monitor
differ
postinfect
time
h
rafp
protein
express
reach
highest
level
approxim
mgl
medium
volum
infecti
baculoviru
inocula
harvest
h
postinfect
express
rafp
volum
infecti
baculoviru
inocula
statist
differ
compar
volum
group
p
figur
red
line
detect
bioactiv
rafp
present
studi
select
human
liver
cell
line
bel
examin
effect
rafp
cellular
prolifer
first
observ
express
afpr
result
reveal
bel
express
afpr
receptor
locat
cell
membran
figur
second
bel
cell
treat
rafp
eafp
mgl
h
htdr
incorpor
result
indic
treatment
rafp
eafp
content
htdr
bel
cell
markedli
enhanc
figur
group
respect
also
select
rafp
eafp
mgl
cotreat
human
afp
antibodi
antiafp
result
show
antiafp
mgl
antagon
effect
rafp
eafp
figur
group
respect
chang
concentr
rafp
eafp
mgl
result
indic
htdr
content
bel
cell
markedli
enhanc
dosedepend
manner
peak
increas
reach
compar
control
group
figur
red
blue
line
antiafp
mgl
antagon
effect
rafp
eafp
concentr
rafp
eafp
increas
antagon
effect
decreas
figur
green
purpl
line
use
mtt
method
analys
effect
rafp
eafp
mgl
prolifer
bel
cell
result
also
demonstr
rafp
eafp
stimul
prolifer
bel
cell
figur
addit
antiafp
revers
effect
rafp
eafp
figur
result
demonstr
effect
rafp
cellular
prolifer
similar
eafp
hsa
show
obviou
influenc
prolifer
bel
cell
rafp
express
bactobac
system
solubl
stabl
monom
bioactiv
similar
human
afp
extract
blood
ip
ph
extract
human
afp
great
deal
human
cord
blood
need
difficult
purifi
express
rafp
bactobac
system
allow
larg
amount
purifi
bioactiv
protein
obtain
without
need
human
cord
blood
rafp
may
allow
studi
biochem
featur
human
afp
drug
screen
human
afp
express
previous
report
e
coli
express
system
yeast
milk
transgen
goat
express
system
produc
low
amount
human
afp
exampl
human
afp
express
e
coli
deposit
bacteri
inclus
bodi
subject
harsh
denatur
human
afp
express
yeast
indistinguish
immunolog
authent
human
afp
human
afp
produc
yeast
contain
seven
extra
amino
acid
residu
nterminu
present
matur
human
afp
purif
human
afp
express
milk
transgen
goat
difficult
time
consum
problem
human
afp
produc
bactobac
system
bactobac
system
achiev
success
protein
express
level
potenti
drug
applic
rafp
produc
bactobac
system
highli
express
easili
purifi
bioactiv
similar
nativ
human
afp
find
aid
clinic
research
immunomodulatori
function
protein
optim
yield
rafp
protein
postinfect
time
consid
recombin
protein
express
intracellularli
need
time
modifi
transport
extracellular
space
thu
best
harvest
time
depend
protein
experi
optim
rafp
express
found
mani
cell
die
lyse
h
therefor
best
harvest
time
approxim
h
effect
extracellular
human
afp
cellular
prolifer
mainli
achiev
signal
transduct
mediat
afpr
previous
found
bel
cell
express
afpr
present
studi
found
afpr
highli
express
membran
bel
cell
result
provid
evid
effect
extracellular
human
afp
prolifer
bel
cell
mediat
membranebound
afpr
previous
found
human
afp
bound
afpr
might
activ
camp
ca
stimul
transduct
cellular
signal
stimul
nra
cmyc
express
lead
promot
prolifer
nih
cell
bel
cell
present
studi
rafp
eafp
play
similar
role
prolifer
bel
cell
suggest
rafp
harbour
biolog
characterist
ident
eafp
human
afp
protein
specif
express
human
hepatocellular
carcinoma
hcc
cell
previous
found
cytoplasm
human
afp
could
interact
signal
molecul
retino
acid
phosphatas
tensin
homologu
pten
interact
inhibit
transduct
apoptot
signal
activ
growth
signal
led
promot
prolifer
drug
resist
liver
cancer
cell
result
suggest
human
afp
may
interact
signal
molecul
present
studi
success
express
purifi
human
afp
protein
also
found
bioactiv
human
afp
protein
similar
cytoplasm
human
afp
recombinantli
express
human
afp
solubl
stabl
use
identifi
signal
molecul
potenti
drug
interact
surfac
plasmon
reson
spr
conclus
present
studi
demonstr
success
express
purif
rafp
pave
way
futur
structur
function
studi
human
afp
